Promoter group pledges 5.44 percent shares to secure debentures

Ownership Changes View source PDF Explain this filing

SYMBIOTEC · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.0%Reaction day

₹1135.05

prior close

₹1116.20

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-0.1% vs market

On the reaction day the stock moved 0.1 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

+0.1

15m

+0.0

30m

-0.3

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

+0.0+0.1-0.1

Next day

-4.4-3.2-1.2

-8.1-3.3-4.8

-8.1-2.5-5.6

-3.1-0.9-2.2

+2.4-1.1+3.5

-6.5+0.6-7.2

15d

+1.6-1.4+2.9

-3.3-3.3+0.0

———

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Beacon Trusteeship Ltd disclosed creation of encumbrance on 34,93,464 equity shares (5.44 percent of capital) of Symbiotec Pharmalab by promoter group members. The pledge secures non-convertible debentures issued by Satwani Holdings (India) Pvt Ltd under a December 2025 trust deed. Pledgors include Anil Satwani, Sushil Satwani, Kashish Satwani, and Satwani Holdings LLP. Pledge dates were September 8 and 9, 2026. A covenant triggers debt repayment if promoter group unencumbered holding falls below 26 percent.

Likely market impact

Shares are pledged, not sold. Signals debt raised against promoter stake; risk if promoter holding approaches 26 percent threshold.